Muscle Relaxants
Methocarbamol
Methocarbamol is a muscle relaxant used with rest and physical therapy for discomfort from acute, painful musculoskeletal conditions in people 16 and older. It is sold as generic tablets (the Robaxin brand tablets are discontinued), as Atmeksi oral suspension and as an injection given by clinicians. It can cause drowsiness and dizziness, and the tablet labels advise against use in pregnancy unless the prescriber judges that the benefits outweigh the possible hazards.
This page is general information about a medication and how cash prices for it are set. It is not medical advice and does not replace the label, your prescriber or your pharmacist. How we handle medical information
Generic 500 and 750 mg tablets come from many makers and 1,000 mg tablets from few; the Robaxin and Robaxin-750 brand tablets are listed as discontinued. Atmeksi has no generic. The injection is sold as Robaxin and as generics.
About Methocarbamol
The labels say how methocarbamol works in humans has not been established but may be due to general depression of the central nervous system, and that it has no direct action on the contractile mechanism of skeletal muscle, the motor end plate or the nerve fiber. It is labeled as an adjunct to rest, physical therapy and other measures for relief of discomfort from acute, painful musculoskeletal conditions; safety and effectiveness have not been established under age 16. Adults usually take 6 grams a day in four doses for the first 48 to 72 hours, and up to 8 grams a day may be given for severe conditions; after that the dose can usually be lowered to about 4 grams a day. MedlinePlus says older adults should not usually take it, because it is not as safe or as effective as other medicines that can treat the same condition.
There is no boxed warning. Methocarbamol must not be taken by anyone allergic to it. It may depress the central nervous system, so it can impair driving or operating machinery, and its effects add to those of alcohol and other sedatives. Overdose often involves alcohol or other sedating drugs and can cause nausea, drowsiness, blurred vision, low blood pressure, seizures and coma; deaths have been reported. Reactions reported with methocarbamol include drowsiness, dizziness, headache, nausea, blurred vision, double vision, confusion, a slow heartbeat, flushing, low blood pressure, fainting, jaundice, a low white blood cell count, seizures and allergic reactions, some severe. MedlinePlus adds that it can turn urine black, blue or green and that a rash or itching should be reported to the doctor right away.
The tablet labels say safe use in pregnancy has not been established and that fetal and congenital abnormalities have been reported after exposure in the womb, so it should not be used by women who are or may become pregnant, particularly early in pregnancy, unless the prescriber judges that the benefits outweigh the possible hazards. The newer Atmeksi label instead says case reports over decades of use have not identified an increased risk of major birth defects or miscarriage. Whether it passes into human milk is not known, so the tablet labels advise caution when breastfeeding. It may weaken pyridostigmine, so people with myasthenia gravis who take an anticholinesterase drug use it with caution, and it can interfere with some urine screening tests for 5-HIAA and VMA. Atmeksi, a suspension approved in July 2025, is the only liquid taken by mouth. The injection, given by a clinician into a vein or muscle, is not used with known or suspected kidney disease, because of the polyethylene glycol it contains.
Taking Methocarbamol
- How to take it
- Exactly as prescribed, usually four times a day at first and later three to six times a day, alongside rest and physical therapy. Shake Atmeksi for at least 30 seconds before each dose. Avoid driving or operating machinery until you know how it affects you.
- If you miss a dose
- Take it as soon as you remember, unless it is almost time for the next dose; then skip the missed dose and carry on as usual. Do not take a double dose.
- Storage
- At room temperature in the original, tightly closed container, away from excess heat and moisture (not in the bathroom), out of reach of children.
- Interactions to know about
- Alcohol and other sedating medicines add to drowsiness and dizziness. It may weaken pyridostigmine, used for myasthenia gravis. It can interfere with some urine screening tests for 5-HIAA and VMA, so tell the lab that you take it.
This summarizes the official prescribing information. Your prescriber’s and pharmacist’s instructions, and the leaflet that comes with your medicine, take priority.
Why the cash price for Methocarbamol differs from pharmacy to pharmacy
Methocarbamol tablets are filled with generics from many makers, so quotes for the same course differ by each pharmacy’s fee and markup and by whether methocarbamol is on its flat-price generic list.
Each day’s dose takes several tablets, so the quantity written shapes the quote, and each strength is quoted on its own; 1,000 mg tablets have few makers. Atmeksi has no generic and is priced as a brand.
Upload it and licensed pharmacies reply with their own cash price. You pay the pharmacy, not us.
Ways to pay less for Methocarbamol without insurance
- Ask whether methocarbamol tablets are on the pharmacy’s flat-price generic list, and compare more than one pharmacy.
- Ask for quotes on your dose in more than one tablet strength, and have the prescription written for the one that suits you.
- Ask the prescriber how many days you need it, so the quantity matches a short course.
- If Atmeksi is prescribed and you can swallow tablets, ask the prescriber whether tablets would suit you.
- Upload the prescription to Script Unlock so licensed pharmacies can quote their cash price. You pay the pharmacy directly.
How Script Unlock gets you a cash price for Methocarbamol
Prices on this site come from pharmacies responding to a real prescription. We do not publish estimated, average or "typical" prices, because none of those would be your price.
- 1You upload your prescription
A photo of your Methocarbamol prescription is enough. Nothing is sold on the site; you are asking pharmacies to quote.
- 2Licensed pharmacies respond
Pharmacies that Script Unlock has verified see the request and each can reply with its own cash price for your exact drug, strength and quantity.
- 3You choose and pay the pharmacy
You compare the responses, pick a pharmacy, and pay that pharmacy directly when you collect. Script Unlock never takes a patient payment and never sets the price.
Questions to ask your pharmacist about Methocarbamol
- 1.How many tablets or milliliters should I take at each dose, and for how many days?
- 2.Can I drive or drink alcohol while I take it?
- 3.Is it safe with my myasthenia gravis medicine, sleep medicine or pain medicine?
- 4.Should I tell the lab that I take it before a urine test?
Where Methocarbamol fits
Related medications
Sources
- FDA-approved labeling on DailyMed (methocarbamol)
- DailyMed, methocarbamol tablets 500 and 750 mg (Granules), updated December 2025
- DailyMed, methocarbamol tablets 500, 750 and 1,000 mg (Bostal), updated February 2026
- DailyMed, Atmeksi (methocarbamol) oral suspension prescribing information
- DailyMed, Robaxin injectable (Hikma) prescribing information
- MedlinePlus drug information (National Library of Medicine)
- MedlinePlus, methocarbamol
- FDA Orange Book (approved generics and therapeutic equivalence)
- Drugs@FDA, Robaxin and Robaxin-750 tablets (NDA 011011): discontinued
- Drugs@FDA, Atmeksi oral suspension (NDA 219843), approved July 2025
- Drugs@FDA, methocarbamol tablets including 1,000 mg (ANDA 200958)
Script Unlock is a marketplace that lets licensed pharmacies quote a cash price on your prescription. It does not prescribe, dispense or sell medication, does not process patient payments, and does not give medical advice. Always follow the instructions of your prescriber and pharmacist and read the medication guide supplied with your medicine.